Arnaud Papin

Company: Merck

Job title: Global Marketing Director, Precision Medicine

Seminars:

Re-Defining Response Monitoring: Where are we Today to Accurately Predict Prognosis and How Does LBx Utility Differ Between Different Cancers? 9:30 am

• The landscape is changing very quickly, with more entrants into the industry and increasingly promising data being announced on a regular basis • As non-invasive testing comes to fruition, it’s important we recognise how the industry is evolving and identifying where liquid biopsy can permit the more comprehensive study of disease resulting in patient…Read more